blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2224982

EP2224982 - DUAL-CHAMBER INJECTION DEVICE HAVING GAS-PERMEABLE MEMBRANE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.05.2014
Database last updated on 15.06.2024
Most recent event   Tooltip04.09.2015Lapse of the patent in a contracting state
New state(s): MT
published on 07.10.2015  [2015/41]
Applicant(s)For all designated states
Sanofi-Aventis Deutschland GmbH
Brüningstrasse 50
65929 Frankfurt am Main / DE
[2010/36]
Inventor(s)01 / KÜHN, Bernd
c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main / DE
 [2010/36]
Application number, filing date08862357.405.12.2008
[2010/36]
WO2008EP10318
Priority number, dateEP2007002461319.12.2007         Original published format: EP 07024613
[2010/36]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report
No.:WO2009077091
Date:25.06.2009
Language:DE
[2009/26]
Type: A1 Application with search report 
No.:EP2224982
Date:08.09.2010
Language:DE
The application published by WIPO in one of the EPO official languages on 25.06.2009 takes the place of the publication of the European patent application.
[2010/36]
Type: B1 Patent specification 
No.:EP2224982
Date:03.07.2013
Language:DE
[2013/27]
Search report(s)International search report - published on:EP25.06.2009
ClassificationIPC:A61M5/28, A61M5/38
[2013/01]
CPC:
A61M5/385 (EP,US); A61M5/284 (EP,US); A61M2005/3104 (EP,US);
A61M2005/3123 (EP,US); A61M2205/7509 (EP,US); A61M2205/7536 (EP,US);
A61M5/3129 (EP,US); A61M5/3134 (EP,US) (-)
Former IPC [2010/36]A61M5/38, A61J1/06, A61M5/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/36]
Extension statesAL19.07.2010
BA19.07.2010
MK19.07.2010
RS19.07.2010
TitleGerman:ZWEIKAMMER-SPRITZENVORRICHTUNG MIT GASDURCHLÄSSIGER MEMBRAN[2010/36]
English:DUAL-CHAMBER INJECTION DEVICE HAVING GAS-PERMEABLE MEMBRANE[2010/36]
French:SYSTÈME DE SERINGUE À DEUX CHAMBRES COMPORTANT UNE MEMBRANE PERMÉABLE AUX GAZ[2010/36]
Entry into regional phase19.07.2010National basic fee paid 
19.07.2010Designation fee(s) paid 
19.07.2010Examination fee paid 
Examination procedure19.07.2010Examination requested  [2010/36]
04.09.2010Amendment by applicant (claims and/or description)
23.02.2012Despatch of a communication from the examining division (Time limit: M04)
13.06.2012Reply to a communication from the examining division
18.01.2013Communication of intention to grant the patent
22.05.2013Fee for grant paid
22.05.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  23.02.2012
Opposition(s)04.04.2014No opposition filed within time limit [2014/24]
Fees paidRenewal fee
15.12.2010Renewal fee patent year 03
12.12.2011Renewal fee patent year 04
11.12.2012Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipBG03.07.2013
EE03.07.2013
HR03.07.2013
LT03.07.2013
LV03.07.2013
MC03.07.2013
MT03.07.2013
RO03.07.2013
SK03.07.2013
IS03.11.2013
LU05.12.2013
[2015/41]
Former [2015/35]BG03.07.2013
EE03.07.2013
HR03.07.2013
LT03.07.2013
LV03.07.2013
MC03.07.2013
RO03.07.2013
SK03.07.2013
IS03.11.2013
LU05.12.2013
Former [2014/38]EE03.07.2013
HR03.07.2013
LT03.07.2013
LV03.07.2013
MC03.07.2013
RO03.07.2013
SK03.07.2013
IS03.11.2013
LU05.12.2013
Former [2014/23]EE03.07.2013
HR03.07.2013
LT03.07.2013
LV03.07.2013
RO03.07.2013
SK03.07.2013
IS03.11.2013
Former [2014/22]HR03.07.2013
LT03.07.2013
LV03.07.2013
RO03.07.2013
IS03.11.2013
Former [2014/12]HR03.07.2013
LT03.07.2013
LV03.07.2013
IS03.11.2013
Former [2014/10]HR03.07.2013
LT03.07.2013
IS03.11.2013
Former [2014/09]HR03.07.2013
LT03.07.2013
Former [2014/08]LT03.07.2013
Cited inInternational search[X]US4226236  (GENESE JOSEPH N) [X] 1-17,20 * column 2, line 34 - column 4, line 2; figures 1-6 *;
 [AD]US4373535  (MARTELL MICHAEL D [US]) [AD] 11 * column 4, lines 9-31 *;
 [A]US5114421  (POLAK ROBERT B [US]) [A] 1-17,20 * column 10, line 55; figures 5-9 *;
 [AD]WO2006007592  (WEST PHARM SERV INC [US]) [AD] 12,13 * column 2, lines 40-46 * * page 4, lines 18,19 ** page 7, lines 11-28 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.